Rita Jain
InvestorBoard Member at Avalo Therapeutics
About
Rheumatologist with over two decades of biopharmaceutical leadership in clinical strategy and regulatory affairs across immunology, inflammation, nephrology, and rare diseases. Most recently Executive Vice President and Chief Medical Officer at ChemoCentryx where she advanced development of Tavneos (avacopan) prior to Amgen acquisition. Previously SVP and CMO at Akebia and held key positions at AbbVie, Pfizer, and Immunovant.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Gilla Kaplan
Board Member at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics
Frequently asked questions
- Who is Rita Jain?
- Rheumatologist with over two decades of biopharmaceutical leadership in clinical strategy and regulatory affairs across immunology, inflammation, nephrology, and rare diseases. Most recently Executive Vice President and Chief Medical Officer at ChemoCentryx where she advanced development of Tavneos (avacopan) prior to Amgen acquisition. Previously SVP and CMO at Akebia and held key positions at AbbVie, Pfizer, and Immunovant.
- Where does Rita Jain work?
- Rita Jain is Board Member at Avalo Therapeutics.